1. Market Research
  2. > Pharmaceutical
  3. > Drug Delivery Market Trends
  4. > European Injectable Drug Delivery Market by Type, Therapeutic, Usage Pattern, Administration, End User - Forecast to 2020

The European injectable drug delivery market is expected to reach $207.3 billion by 2020 from $114.7 billion in 2015, growing at a CAGR of 12.6% from 2015 to 2020. The market is categorized on the basis of type, therapeutic application, usage pattern, mode of administration, end user, and region. The therapeutic application market is further segmented into autoimmune diseases, hormonal disorders, oncology, orphan diseases, and other therapeutic applications. The oncology segment is expected to witness the highest CAGR in the forecast period.

Factors such as rising incidences of chronic diseases, growth of the biologics market, demand of self-injection devices, and technological advancements, are driving the growth of the European injectable drug delivery market. In addition, Europe is emphasizing on innovation of formulations and improving the delivery of pharmaceuticals. For instance, in November 2012, COMPACT (Collaboration on the Optimization of Macromolecular Pharmaceutical Access to Cellular Targets), a public-private consortium funded by the Innovative Medicines Initiative (IMI), announced the launch of a €30 million ($38.5 million) project, which focuses on improving the delivery of biopharmaceuticals. The consortium would address the major bottlenecks in the development of novel innovative medicines based on biological macromolecules, such as proteins/peptides and oligonucleotides. Such investments are fueling the growth of the market.

Germany is expected to be the fastest-growing country in the European injectable drug delivery market. High growth in this market can be attributed to the increased demand for injectable insulin and self-injection devices, particularly pen injectors which are used in the treatment of diabetes.

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the European injectable drug delivery market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report can use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

- Market Penetration: Comprehensive information on the product portfolios of the top players in the European injectable drug delivery market. The report analyzes this market by type, therapeutic application, usage pattern, mode of administration, end user, and region
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the European injectable drug delivery market
- Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of leading players in the European injectable drug delivery market
- Market Development: Comprehensive information about lucrative markets. The report analyzes the market for various European injectable drug delivery across countries
- Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the European injectable drug delivery market

Table Of Contents

European Injectable Drug Delivery Market by Type, Therapeutic, Usage Pattern, Administration, End User - Forecast to 2020
TABLE OF CONTENTS

1 INTRODUCTION 23
1.1 OBJECTIVES OF THE STUDY 23
1.2 MARKET DEFINITION 23
1.3 MARKET SCOPE 24
1.3.1 MARKETS COVERED 24
1.3.2 YEARS CONSIDERED FOR THE STUDY 27
1.4 CURRENCY 27
1.5 LIMITATIONS 28
1.6 MARKET STAKEHOLDERS 28
2 RESEARCH METHODOLOGY 29
2.1 MARKET SIZE ESTIMATION 30
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 32
2.3 KEY DATA FROM SECONDARY SOURCES 34
2.4 KEY DATA FROM PRIMARY SOURCES 34
2.5 ASSUMPTIONS FOR THE STUDY 35
3 EXECUTIVE SUMMARY 36
4 PREMIUM INSIGHTS 40
4.1 EUROPEAN INJECTABLE DRUG DELIVERY MARKET, BY FORMULATION 40
4.2 EUROPEAN INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN 41
4.3 EUROPEAN INJECTABLE DRUG DELIVERY MARKET, BY END USER 42
4.4 EUROPEAN INJECTABLE DRUG DELIVERY MARKET, BY THERAPEUTIC APPLICATION 43
5 MARKET OVERVIEW 44
5.1 INTRODUCTION 45
5.2 MARKET SEGMENTATION 45
5.2.1 BY TYPE 46
5.2.2 BY THERAPEUTIC APPLICATION 46
5.2.3 BY USAGE PATTERN 47
5.2.4 BY MODE OF ADMINISTRATION 47
5.2.5 BY END USER 47
5.2.6 BY REGION 48
5.3 MARKET DYNAMICS 48
5.4 DRIVERS 50
5.4.1 RISING PREVALENCE OF CHRONIC DISEASES 50
5.4.2 INCREASE IN DEMAND FOR SELF -INJECTION DEVICES 50
5.4.3 GROWTH OF THE BIOLOGICS MARKET 51
5.4.4 TECHNOLOGICAL ADVANCEMENTS 51
5.5 RESTRAINTS 52
5.5.1 NEEDLESTICK INJURIES AND INFECTIONS 52
5.5.2 RISE OF ALTERNATE MODE OF DRUG DELIVERY 53
5.6 OPPORTUNITIES 54
5.6.1 INCREASE IN DEMAND FOR BIOSIMILARS AND GENERIC INJECTABLES 54
5.6.1.1 Biosimilars 54
5.6.1.2 Generic injectables 54
5.6.2 CONTRACEPTIVE INJECTABLES 54
5.7 CHALLENGES 55
5.7.1 PRODUCT RECALL 55
5.7.2 REGULATORY HURDLES 56
5.7.3 STABILITY OF THE PRODUCT 56
5.7.4 STERILITY OF INJECTIONS 56
6 EUROPEAN INJECTABLE DRUG DELIVERY MARKET, BY TYPE 58
6.1 INTRODUCTION 59
6.2 DEVICES 60
6.2.1 CONVENTIONAL INJECTION DEVICES 62
6.2.1.1 By Material 64
6.2.1.1.1 Glass 65
6.2.1.1.2 Plastic 66
6.2.1.2 By Product 68
6.2.1.2.1 Fillable syringes 68
6.2.1.2.2 Prefilled syringes 70
6.2.1.3 By Usability 71
6.2.1.3.1 Reusable syringes 72
6.2.1.3.2 Disposable syringes 73
6.2.2 SELF-INJECTION DEVICES 74
6.2.2.1 Needle-free injectors 76
6.2.2.1.1 By product 78
6.2.2.1.1.1 Fillable needle-free injectors 79
6.2.2.1.1.2 Prefilled needle-free injectors 80
6.2.2.1.2 By technology 81
6.2.2.1.2.1 Jet-based needle-free injectors 82
6.2.2.1.2.2 Spring-based Needle-free injectors 83
6.2.2.1.2.3 Laser-powered needle-free injectors 84
6.2.2.1.2.4 Vibration-based needle-free injectors 85
6.2.2.1.3 By usability 86
6.2.2.1.3.1 Reusable needle-free injectors 87
6.2.2.1.3.2 Disposable needle-free injectors 88
6.2.2.2 Autoinjectors 89
6.2.2.2.1 By product 90
6.2.2.2.1.1 Fillable autoinjectors 91
6.2.2.2.1.2 Prefilled autoinjectors 92
6.2.2.2.2 By technology 94
6.2.2.2.2.1 Automated Autoinjectors 95
6.2.2.2.2.2 Manual Autoinjectors 96
6.2.2.2.3 By design 97
6.2.2.2.3.1 Standardized Autoinjectors 98
6.2.2.2.3.2 Customized Autoinjectors 100
6.2.2.2.4 By usability 101
6.2.2.2.4.1 Reusable autoinjectors 102
6.2.2.2.4.2 Disposable Autoinjectors 103
6.2.2.3 Pen injectors 104
6.2.2.3.1 By product 106
6.2.2.3.1.1 Single-chambered Pen Injectors 107
6.2.2.3.1.2 Dual-chambered Pen Injectors 108
6.2.2.3.2 By design 109
6.2.2.3.2.1 Standard Pen Injectors 110
6.2.2.3.2.2 Customized Pen Injectors 112
6.2.2.3.3 By usability 113
6.2.2.3.3.1 Reusable Pen Injectors 114
6.2.2.3.3.2 Disposable Pen Injectors 115
6.2.2.4 Wearable injectors 116
6.2.2.5 Other Devices 118
6.3 FORMULATIONS 120
6.3.1 CONVENTIONAL DRUG DELIVERY 121
6.3.1.1 SOLUTIONS 122
6.3.1.2 RECONSTITUTED/LYOPHILIZED FORMULATIONS 123
6.3.1.3 SUSPENSIONS 124
6.3.1.4 EMULSIONS 125
6.3.2 NOVEL DRUG DELIVERY FORMULATIONS 125
6.3.2.1 COLLOIDAL DISPERSIONS 127
6.3.2.1.1 LIPOSOMES 128
6.3.2.1.2 NIOSOMES 129
6.3.2.1.3 POLYMERIC/MIXED MICELLE 129
6.3.2.1.4 NANOPARTICLES 130
6.3.2.1.4.1 NANOSUSPENSIONS 132
6.3.2.1.4.2 NANOEMULSIONS/MICROEMULSIONS 132
6.3.2.1.4.3 SOLID-LIPID NANOPARTICLES 133
6.3.2.2 MICROPARTICLES 134
6.3.2.2.1 MICROSPHERES 135
6.3.2.2.2 MICROCAPSULES 136
6.3.3 LONG-ACTING INJECTION FORMULATIONS 136
7 EUROPEAN INJECTABLE DRUG DELIVERY MARKET, BY THERAPEUTIC APPLICATION 138
7.1 INTRODUCTION 139
7.2 AUTOIMMUNE DISEASES 141
7.2.1 RHEUMATOID ARTHRITIS 143
7.2.2 MULTIPLE SCLEROSIS 143
7.2.3 CROHN'S DISEASE 144
7.2.4 PSORIASIS 145
7.2.5 OTHER AUTOIMMUNE DISEASES 146
7.3 HORMONAL DISORDERS 147
7.3.1 DIABETES 148
7.3.2 ANEMIA 149
7.3.3 REPRODUCTIVE HEALTH DISEASE 149
7.3.4 ANTITHROMBOTIC/THROMBOLYTIC THERAPY 150
7.3.5 OSTEOPOROSIS 151
7.3.6 GROWTH HORMONE DEFICIENCY (GHD) 152
7.4 ORPHAN DISEASES 153
7.5 ONCOLOGY 154
7.6 OTHERS 155
7.6.1 PAIN MANAGEMENT 156
7.6.2 ALLERGY TREATMENT 157
7.6.3 AESTHETIC TREATMENT 158
7.6.4 HEPATITIS C 159
7.6.5 HEMOPHILIA 160
8 EUROPEAN INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN 161
8.1 INTRODUCTION 162
8.2 CURATIVE CARE 163
8.3 IMMUNIZATION 164
8.4 OTHERS (BLOOD TRANSFUSION AND BLOOD PRODUCTS AND CONTRACEPTIVES) 165
9 EUROPEAN INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION 166
9.1 INTRODUCTION 167
9.2 SKIN 168
9.3 CIRCULATORY/MUSCULOSKELETAL 169
9.4 ORGANS 170
9.5 CENTRAL NERVOUS SYSTEM 171

10 EUROPEAN INJECTABLE DRUG DELIVERY MARKET, BY END USER 172
10.1 INTRODUCTION 173
10.2 HOSPITALS AND CLINICS 175
10.3 HOME CARE SETTINGS 176
10.4 RESEARCH LABORATORIES 176
10.5 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 177
10.6 OTHER END USERS 178
11 EUROPEAN INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY 179
11.1 INTRODUCTION 180
11.1.1 GERMANY 181
11.1.2 FRANCE 185
11.1.3 U.K. 189
11.1.4 ITALY 193
11.1.5 SPAIN 197
11.1.6 REST OF EUROPE (ROE) 201
12 COMPETITIVE LANDSCAPE 206
12.1 OVERVIEW 206
12.2 MARKET SHARE ANALYSIS 207
12.3 COMPETITIVE SITUATIONS and TRENDS 208
12.3.1 NEW PRODUCT LAUNCHES 209
12.3.2 FDA APPROVALS 211
12.3.3 EXPANSIONS AND INVESTMENTS 212
12.3.4 ACQUISITIONS 212
12.3.5 COLLABORATIONS and AGREEMENTS 213
13 COMPANY PROFILES 214
(Overview, Financials, Products and Services, Strategy, and Developments)*

13.1 INTRODUCTION 214
13.2 BAXTER INTERNATIONAL, INC. 215
13.3 BECTON, DICKINSON AND COMPANY 218
13.4 GERRESHEIMER AG 221
13.5 PFIZER, INC. 223
13.6 SCHOTT AG 226
13.7 ALKERMES PLC. 228
13.8 ELI LILLY AND COMPANY 230
13.9 SANDOZ 232
13.10 TERUMO CORPORATION 235

13.11 TEVA PHARMACEUTICAL INDUSTRIES LTD. 237

*Details on Financials, Product and Services, Strategy, and Developments might not be captured in case of unlisted companies.
14 APPENDIX 239
14.1 INSIGHTS FROM INDUSTRY EXPERTS 239
14.2 DISCUSSION GUIDE 240
14.3 OTHER RECENT DEVELOPMENTS 244
14.4 AVAILABLE CUSTOMIZATIONS 245
14.5 RT: REAL-TIME MARKET INTELLIGENCE 245
14.6 RELATED REPORTS 246


LIST OF TABLES

TABLE 1 INCREASE IN DEMAND FOR SELF-INJECTION DEVICES IS BOOSTING THE MARKET GROWTH 52
TABLE 2 NEEDLESTICK INJURIES AND INFECTIONS ARE RESTRAINING THE MARKET GROWTH 53
TABLE 3 INCREASE IN DEMAND OF BIOSIMILARS OFFERS AN ARRAY OF OPPORTUNITIES FOR THE MARKET 55
TABLE 4 PRODUCT RECALL POSE SIGNIFICANT CHALLENGES TO MARKET GROWTH 57
TABLE 5 EUROPE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 59
TABLE 6 EUROPE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 59
TABLE 7 EUROPE: INJECTABLE DRUG DELIVERY DEVICES MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 60
TABLE 8 EUROPE: INJECTABLE DRUG DELIVERY DEVICES MARKET SIZE, BY TYPE,
2013-2020 (MILLION UNITS) 61
TABLE 9 EUROPE: INJECTABLE DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 61
TABLE 10 EUROPE: INJECTABLE DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (MILLION UNITS) 62
TABLE 11 EUROPE: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 63
TABLE 12 EUROPE: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY COUNTRY,
2013-2020 (MILLION UNITS) 63
TABLE 13 EUROPE: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY MATERIAL,
2013-2020 ($MILLION) 64
TABLE 14 EUROPE: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY MATERIAL,
2013-2020 (MILLION UNITS) 64
TABLE 15 EUROPE: CONVENTIONAL GLASS INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 65
TABLE 16 EUROPE: CONVENTIONAL GLASS INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (MILLION UNITS) 66
TABLE 17 EUROPE: CONVENTIONAL PLASTIC INJECTION DEVICES MARKET SIZE,
BY COUNTRY, 2013-2020 ($MILLION) 67
TABLE 18 EUROPE: CONVENTIONAL PLASTIC INJECTION DEVICES MARKET SIZE,
BY COUNTRY, 2013-2020 (MILLION UNITS) 67
TABLE 19 EUROPE: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY PRODUCT,
2013-2020 ($MILLION) 68
TABLE 20 EUROPE: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY PRODUCT,
2013-2020 (MILLION UNITS) 68
TABLE 21 EUROPE: CONVENTIONAL FILLABLE INJECTION DEVICES MARKET SIZE,
BY COUNTRY, 2013-2020 ($MILLION) 69
TABLE 22 EUROPE: CONVENTIONAL FILLABLE INJECTION DEVICES MARKET SIZE,
BY COUNTRY, 2013-2020 (MILLION UNITS) 69
TABLE 23 EUROPE: CONVENTIONAL PREFILLED INJECTION DEVICES MARKET SIZE,
BY COUNTRY, 2013-2020 ($MILLION) 70
TABLE 24 EUROPE: CONVENTIONAL PREFILLED INJECTION DEVICES MARKET SIZE,
BY COUNTRY, 2013-2020 (MILLION UNITS) 71
TABLE 25 EUROPE: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY USABILITY,
2013-2020 ($MILLION) 71
TABLE 26 EUROPE: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY USABILITY,
2013-2020 (MILLION UNITS) 72
TABLE 27 EUROPE: CONVENTIONAL REUSABLE INJECTION DEVICES MARKET SIZE,
BY COUNTRY, 2013-2020 ($MILLION) 72
TABLE 28 EUROPE: CONVENTIONAL REUSABLE INJECTION DEVICES MARKET SIZE,
BY COUNTRY, 2013-2020 (MILLION UNITS) 73
TABLE 29 EUROPE: CONVENTIONAL DISPOSABLE INJECTION DEVICES MARKET SIZE,
BY COUNTRY, 2013-2020 ($MILLION) 73
TABLE 30 EUROPE: CONVENTIONAL DISPOSABLE INJECTION DEVICES MARKET SIZE,
BY COUNTRY, 2013-2020 (MILLION UNITS) 74
TABLE 31 EUROPE: SELF-INJECTION DEVICES MARKET, BY TYPE, 2013-2020 ($MILLION) 75
TABLE 32 EUROPE: SELF-INJECTION DEVICES MARKET, BY TYPE, 2013-2020 (MILLION UNITS) 75
TABLE 33 EUROPE: SELF-INJECTION DEVICES MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 75
TABLE 34 EUROPE: SELF-INJECTION DEVICES MARKET SIZE, BY COUNTRY,
2013-2020 (MILLION UNITS) 76
TABLE 35 EUROPE: NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 77
TABLE 36 EUROPE: NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY,
2013-2020 (MILLION UNITS) 77
TABLE 37 EUROPE: NEEDLE-FREE INJECTORS MARKET SIZE, BY PRODUCT,
2013-2020 ($MILLION) 78
TABLE 38 EUROPE: NEEDLE-FREE INJECTORS MARKET SIZE, BY PRODUCT,
2013-2020 (MILLION UNITS) 78
TABLE 39 EUROPE: FILLABLE NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 79
TABLE 40 EUROPE: FILLABLE NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY,
2013-2020 (MILLION UNITS) 79
TABLE 41 EUROPE: PREFILLED NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 80
TABLE 42 EUROPE: PREFILLED NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013-2020 (MILLION UNITS) 80
TABLE 43 EUROPE: NEEDLE-FREE INJECTORS MARKET SIZE, BY TECHNOLOGY,
2013-2020 ($MILLION) 81
TABLE 44 EUROPE: NEEDLE-FREE INJECTORS MARKET SIZE, BY TECHNOLOGY,
2013-2020 (MILLION UNITS) 81
TABLE 45 EUROPE: JET-BASED NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 82
TABLE 46 EUROPE: JET-BASED NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013-2020 (MILLION UNITS) 82
TABLE 47 EUROPE: SPRING-BASED NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 83
TABLE 48 EUROPE: SPRING-BASED NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013-2020 (MILLION UNITS) 83
TABLE 49 EUROPE: LASER-POWERED NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 84
TABLE 50 EUROPE: LASER-POWERED NEEDLE-FREE INJECTORS MARKET, BY COUNTRY, 2013-2020 (MILLION UNITS) 84
TABLE 51 EUROPE: VIBRATION-BASED NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 85
TABLE 52 EUROPE: VIBRATION-BASED NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013-2020 (MILLION UNITS) 85
TABLE 53 EUROPE: NEEDLE-FREE INJECTORS MARKET SIZE, BY USABILITY,
2013-2020 ($MILLION) 86
TABLE 54 EUROPE: NEEDLE-FREE INJECTORS MARKET SIZE, BY USABILITY,
2013-2020 (MILLION UNITS) 86
TABLE 55 EUROPE: REUSABLE NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 87
TABLE 56 EUROPE: REUSABLE NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY,
2013-2020 (MILLION UNITS) 87
TABLE 57 EUROPE: DISPOSABLE NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 88
TABLE 58 EUROPE: DISPOSABLE NEEDLE-FREE INJECTORS MARKET SIZE, BY COUNTRY, 2013-2020 (MILLION UNITS) 89
TABLE 59 EUROPE: AUTOINJECTOR DEVICES MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 89
TABLE 60 EUROPE: AUTOINJECTOR DEVICES MARKET SIZE, BY COUNTRY,
2013-2020 (MILLION UNITS) 90
TABLE 61 EUROPE: AUTOINJECTOR DEVICES MARKET SIZE, BY PRODUCT,
2013-2020 ($MILLION) 90
TABLE 62 EUROPE: AUTOINJECTOR DEVICES MARKET SIZE, BY PRODUCT,
2013-2020 (MILLION UNITS) 91
TABLE 63 EUROPE: FILLABLE AUTOINJECTOR DEVICES MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 91
TABLE 64 EUROPE: FILLABLE AUTOINJECTOR DEVICES MARKET SIZE, BY COUNTRY,
2013-2020 (MILLION UNITS) 92
TABLE 65 EUROPE: PREFILLED AUTOINJECTOR DEVICES MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 93
TABLE 66 EUROPE: PREFILLED AUTOINJECTOR DEVICES MARKET SIZE, BY COUNTRY,
2013-2020 (MILLION UNITS) 93
TABLE 67 EUROPE: AUTOINJECTOR DEVICES MARKET SIZE, BY TECHNOLOGY,
2013-2020 ($MILLION) 94
TABLE 68 EUROPE: AUTOINJECTOR DEVICES MARKET SIZE, BY TECHNOLOGY,
2013-2020 (MILLION UNITS) 94
TABLE 69 EUROPE: AUTOMATED AUTOINJECTORS MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 95
TABLE 70 EUROPE: AUTOMATED AUTOINJECTORS MARKET SIZE, BY COUNTRY,
2013-2020 (MILLION UNITS) 95
TABLE 71 EUROPE: MANUAL AUTOINJECTORS MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 96
TABLE 72 EUROPE: MANUAL AUTOINJECTORS MARKET, BY COUNTRY, 2013-2020 (MILLION UNITS) 96
TABLE 73 EUROPE: AUTOINJECTORS MARKET SIZE, BY DESIGN, 2013-2020 ($MILLION) 97
TABLE 74 EUROPE: AUTOINJECTORS MARKET SIZE, BY DESIGN, 2013-2020 (MILLION UNITS) 97
TABLE 75 EUROPE: STANDARDIZED AUTOINJECTORS MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 98
TABLE 76 EUROPE: STANDARDIZED AUTOINJECTORS MARKET SIZE, BY COUNTRY,
2013-2020 (MILLION UNITS) 99
TABLE 77 EUROPE: CUSTOMIZED AUTOINJECTORS MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 100
TABLE 78 EUROPE: CUSTOMIZED AUTOINJECTORS MARKET SIZE, BY COUNTRY,
2013-2020 (MILLION UNITS) 100
TABLE 79 EUROPE: AUTOINJECTOR MARKET SIZE, BY USABILITY, 2013-2020 ($MILLION) 101
TABLE 80 EUROPE: AUTOINJECTORS MARKET SIZE, BY USABILITY, 2013-2020 (MILLION UNITS) 101
TABLE 81 EUROPE: REUSABLE AUTOINJECTORS MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 102
TABLE 82 EUROPE: REUSABLE AUTOINJECTORS MARKET SIZE, BY COUNTRY,
2013-2020 (MILLION UNITS) 103
TABLE 83 EUROPE: DISPOSABLE AUTOINJECTORS MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 103
TABLE 84 EUROPE: DISPOSABLE AUTOINJECTORS MARKET SIZE, BY COUNTRY,
2013-2020 (MILLION UNITS) 104
TABLE 85 EUROPE: PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 105
TABLE 86 EUROPE: PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013-2020 (MILLION UNITS) 105
TABLE 87 EUROPE: PEN INJECTORS MARKET SIZE, BY PRODUCT, 2013-2020 ($MILLION) 106
TABLE 88 EUROPE: PEN INJECTORS MARKET SIZE, BY PRODUCT, 2013-2020 (MILLION UNITS) 106
TABLE 89 EUROPE: SINGLE-CHAMBERED PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 107
TABLE 90 EUROPE: SINGLE-CHAMBERED PEN INJECTORS MARKET SIZE, BY COUNTRY, 2013-2020 (MILLION UNITS) 107
TABLE 91 EUROPE: DUAL-CHAMBERED PEN INJECTORS MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 108
TABLE 92 EUROPE: DUAL-CHAMBERED PEN INJECTORS MARKET SIZE, BY COUNTRY,
2013-2020 (MILLION UNITS) 109
TABLE 93 EUROPE: PEN INJECTORS MARKET SIZE, BY DESIGN, 2013-2020 ($MILLION) 109
TABLE 94 EUROPE: PEN INJECTORS MARKET SIZE, BY DESIGN, 2013-2020 (MILLION UNITS) 110
TABLE 95 EUROPE: STANDARD PEN INJECTORS MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 110
TABLE 96 EUROPE: STANDARD PEN INJECTORS MARKET SIZE, BY COUNTRY,
2013-2020 (MILLION UNITS) 111
TABLE 97 EUROPE: CUSTOMIZED PEN INJECTORS MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 112
TABLE 98 EUROPE: CUSTOMIZED PEN INJECTORS MARKET, BY COUNTRY,
2013-2020 (MILLION UNITS) 112
TABLE 99 EUROPE: PEN INJECTOR MARKET SIZE, BY USABILITY, 2013-2020 ($MILLION) 113
TABLE 100 EUROPE: PEN INJECTORS MARKET SIZE, BY USABILITY, 2013-2020 (MILLION UNITS) 113
TABLE 101 EUROPE: REUSABLE PEN INJECTORS MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 114
TABLE 102 EUROPE: REUSABLE PEN INJECTORS MARKET SIZE, BY COUNTRY,
2013-2020 (MILLION UNITS) 114
TABLE 103 EUROPE: DISPOSABLE PEN INJECTORS MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 115
TABLE 104 EUROPE: DISPOSABLE PEN INJECTORS MARKET SIZE, BY COUNTRY,
2013-2020 (MILLION UNITS) 116
TABLE 105 EUROPE: WEARABLE INJECTORS MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 117
TABLE 106 EUROPE: WEARABLE INJECTORS MARKET SIZE, BY COUNTRY,
2013-2020 (MILLION UNITS) 117
TABLE 107 EUROPE: OTHER DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 118
TABLE 108 EUROPE: OTHER DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (MILLION UNITS) 119
TABLE 109 EUROPE: INJECTABLE DRUG DELIVERY FORMULATIONS MARKET SIZE, BY TYPE, 2013-2020 ($MILLION) 120
TABLE 110 EUROPE: INJECTABLE DRUG DELIVERY FORMULATIONS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 121
TABLE 111 EUROPE: CONVENTIONAL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY TYPE, 2013-2020 ($MILLION) 121
TABLE 112 EUROPE: CONVENTIONAL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 122
TABLE 113 EUROPE: SOLUTIONS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 123
TABLE 114 EUROPE: RECONSTITUTED/LYOPHILIZED FORMULATIONS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 124
TABLE 115 EUROPE: SUSPENSIONS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 124
TABLE 116 EUROPE: EMULSION MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 125
TABLE 117 EUROPE: NOVEL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 126
TABLE 118 EUROPE: NOVEL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 126
TABLE 119 EUROPE: COLLOIDAL DISPERSION MARKET SIZE, BY TYPE, 2013-2020 ($MILLION) 127
TABLE 120 EUROPE: COLLOIDAL DISPERSION MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 128
TABLE 121 EUROPE: LIPOSOMES MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 128
TABLE 122 EUROPE: NIOSOMES MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 129
TABLE 123 EUROPE: POLYMERIC/MIXED MICELLES MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 130
TABLE 124 EUROPE: NANOPARTICLES MARKET SIZE, BY TYPE, 2013-2020 ($MILLION) 131
TABLE 125 EUROPE: NANOPARTICLES MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 131
TABLE 126 EUROPE: NANOSUSPENSIONS MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 132
TABLE 127 EUROPE: NANOEMULSIONS/MICROEMULSIONS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 133
TABLE 128 EUROPE: SOLID-LIPID NANOPARTICLES MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 133
TABLE 129 EUROPE: MICROPARTICLES MARKET SIZE, BY TYPE, 2013-2020 ($MILLION) 134
TABLE 130 EUROPE: MICROPARTICLES MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 134
TABLE 131 EUROPE: MICROSPHERES MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 135
TABLE 132 EUROPE: MICROCAPSULES MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 136
TABLE 133 EUROPE: LONG-ACTING INJECTION FORMULATIONS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 137
TABLE 134 EUROPE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2013 - 2020 ($MILLION) 140
TABLE 135 EUROPE: INJECTABLE DRUG DELIVERY THERAPEUTIC APPLICATIONS MARKET SIZE, BY COUNTRY, 2013 - 2020 ($MILLION) 141
TABLE 136 EUROPE: AUTOIMMUNE DISEASES MARKET SIZE, BY INDICATION,
2013-2020 ($MILLION) 142
TABLE 137 EUROPE: AUTOIMMUNE DISEASES MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 142
TABLE 138 EUROPE: RHEUMATOID ARTHRITIS MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 143
TABLE 139 EUROPE: MULTIPLE SCLEROSIS MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 144
TABLE 140 EUROPE: CROHN'S DISEASE MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 145
TABLE 141 EUROPE: PSORIASIS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 146
TABLE 142 EUROPE: OTHER AUTOIMMUNE DISEASES MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 146
TABLE 143 EUROPE: HORMONAL DISORDERS MARKET SIZE, BY INDICATION,
2013-2020 ($MILLION) 147
TABLE 144 EUROPE: HORMONAL DISORDERS MARKET SIZE, BY COUNTRY,
2013 -2020 ($MILLION) 147
TABLE 145 EUROPE: DIABETES MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 148
TABLE 146 EUROPE: ANEMIA MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 149
TABLE 147 EUROPE: REPRODUCTIVE HEALTH DISEASE MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 150
TABLE 148 EUROPE: ANTITHROMBOTIC/THROMBOLYTIC THERAPY MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 151
TABLE 149 EUROPE: OSTEOPOROSIS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 152
TABLE 150 EUROPE: GROWTH HORMONE DEFICIENCY (GHD) MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 153
TABLE 151 EUROPE: ORPHAN DISEASES MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 154
TABLE 152 EUROPE: ONCOLOGY MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 155
TABLE 153 EUROPE: OTHER THERAPEUTIC APPLICATIONS MARKET SIZE, BY INDICATION, 2013-2020 ($MILLION) 155
TABLE 154 EUROPE: OTHER THERAPEUTIC APPLICATIONS MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 156
TABLE 155 EUROPE: PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 157
TABLE 156 EUROPE: ALLERGY MANAGEMENT MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 158
TABLE 157 EUROPE: AESTHETIC TREATMENT MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 159
TABLE 158 EUROPE: HEPATITIS C MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 159
TABLE 159 EUROPE: HEMOPHILIA MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 160
TABLE 160 EUROPE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN,
2013 - 2020 ($MILLION) 162
TABLE 161 EUROPE: USAGE PATTERN MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 163
TABLE 162 EUROPE: CURATIVE CARE MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 163
TABLE 163 EUROPE: IMMUNIZATION MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 164
TABLE 164 EUROPE: OTHER USAGE PATTERNS MARKET SIZE, BY COUNTRY,
2013 - 2020 ($MILLION) 165
TABLE 165 EUROPE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY MODE OF ADMINISTRATION, 2013 - 2020 ($MILLION) 167
TABLE 166 EUROPE: MODE OF ADMINISTRATION MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 168
TABLE 167 EUROPE: SKIN ADMINISTRATION MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 168
TABLE 168 EUROPE: CIRCULATORY/MUSCULOSKELETAL ADMINISTRATION MARKET SIZE,
BY COUNTRY, 2013-2020 ($MILLION) 170
TABLE 169 EUROPE: ORGAN ADMINISTRATION MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 170
TABLE 170 EUROPE: CENTRAL NERVOUS SYSTEM ADMINISTRATION, BY COUNTRY,
2013-2020 ($MILLION) 171
TABLE 171 EUROPE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY END USER,
2013-2020 ($MILLION) 174
TABLE 172 EUROPE: END USER MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 174
TABLE 173 EUROPE: HOSPITALS AND CLINICS MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 175
TABLE 174 EUROPE: HOME CARE SETTING MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 176
TABLE 175 EUROPE: RESEARCH LABORATORIES MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 176
TABLE 176 EUROPE: PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET SIZE,
BY COUNTRY, 2013-2020 ($MILLION) 177
TABLE 177 EUROPE: OTHER END USERS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 178
TABLE 178 GERMANY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 181
TABLE 179 GERMANY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE,
2013-2020 ($MILLION) 181
TABLE 180 GERMANY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE,
2013-2020 (MILLION UNITS) 182
TABLE 181 GERMANY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION,
2013-2020 ($MILLION) 182
TABLE 182 GERMANY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2013-2020 ($MILLION) 183
TABLE 183 GERMANY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2013-2020 ($MILLION) 183
TABLE 184 GERMANY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY MODE OF ADMINISTRATION, 2013-2020 ($MILLION) 184
TABLE 185 GERMANY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY END USER,
2013-2020 ($MILLION) 184
TABLE 186 FRANCE :INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 185
TABLE 187 FRANCE :INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE,
2013 - 2020 ($MILLION) 185
TABLE 188 FRANCE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE,
2013 - 2020 (MILLION UNITS) 186
TABLE 189 FRANCE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION,
2013-2020 ($MILLION) 186
TABLE 190 FRANCE: INJECTABLE DRUG DELIVERY MARKET SIZE , BY THERAPEUTIC APPLICATION, 2013-2020 ($MILLION) 187
TABLE 191 FRANCE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN,
2013-2020 ($MILLION) 187
TABLE 192 FRANCE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY MODE OF ADMINISTRATION, 2013-2020 ($MILLION) 188
TABLE 193 FRANCE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY END USER,
2013-2020 ($MILLION) 188
TABLE 194 U.K.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE, 2013-2020 ($MILLION) 189
TABLE 195 U.K.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE,
2013 - 2020 ($MILLION) 189
TABLE 196 U.K.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE, 2013-2020 (MILLION UNITS) 190
TABLE 197 U.K.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION,
2013-2020 ($MILLION) 190
TABLE 198 U.K.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2013-2020 ($MILLION) 191
TABLE 199 U.K.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN,
2013-2020 ($MILLION) 191
TABLE 200 U.K.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY MODE OF ADMINISTRATION, 2013-2020 ($MILLION) 192
TABLE 201 U.K.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY END USER,
2013-2020 ($MILLION) 192
TABLE 202 ITALY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 193
TABLE 203 ITALY: INJECTABLE DRUG DELIVERY MARKET SIZE , BY DEVICE,
2013-2020 ($MILLION) 193
TABLE 204 ITALY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE,
2013-2020 (MILLION UNITS) 194
TABLE 205 ITALY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION,
2013-2020 ($MILLION) 194
TABLE 206 ITALY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2013-2020 ($MILLION) 195
TABLE 207 ITALY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN,
2013-2020 ($MILLION) 195
TABLE 208 ITALY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY MODE OF ADMINISTRATION, 2013-2020 ($MILLION) 196
TABLE 209 ITALY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY END USER,
2013-2020 ($MILLION) 196
TABLE 210 SPAIN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 197
TABLE 211 SPAIN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE,
2013-2020 ($MILLION) 197
TABLE 212 SPAIN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE,
2013-2020 (MILLION UNITS) 198
TABLE 213 SPAIN: INJECTABLE DRUG DELIVERY MARKET SIZE , BY FORMULATION,
2013-2020 ($MILLION) 198
TABLE 214 SPAIN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2013-2020 ($MILLION) 199
TABLE 215 SPAIN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN,
2013-2020 ($MILLION) 199
TABLE 216 SPAIN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY MODE OF ADMINISTRATION, 2013-2020 ($MILLION) 200
TABLE 217 SPAIN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY END USER,
2013-2020 ($MILLION) 200
TABLE 218 ROE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE,
2013-2020 ($MILLION) 201
TABLE 219 ROE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE,
2013-2020 ($MILLION) 202
TABLE 220 ROE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE,
2013-2020 (MILLION UNITS) 202
TABLE 221 ROE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION,
2013-2020 ($MILLION) 203
TABLE 222 ROE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2013-2020 ($MILLION) 203
TABLE 223 ROE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN,
2013-2020 ($MILLION) 204
TABLE 224 ROE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY MODE OF ADMINISTRATION, 2013-2020 ($MILLION) 204
TABLE 225 ROE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY END USER,
2013-2020 ($MILLION) 205
TABLE 226 NEW PRODUCT LAUNCHES (2012-2015) 209
TABLE 227 FDA APPROVALS (2012-2015) 211
TABLE 228 EXPANSIONS AND INVESTMENTS (2012-2015) 212
TABLE 229 ACQUISITIONS (2012-2015) 212
TABLE 230 COLLABORATIONS and AGREEMENTS (2012-2015) 213


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 29
FIGURE 2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 31
FIGURE 3 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 31
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE AND DESIGNATION 32
FIGURE 5 DATA TRIANGULATION METHODOLOGY 33
FIGURE 6 EUROPEAN INJECTABLE DRUG DELIVERY MARKET SNAPSHOT, BY FORMULATION (2015 VS. 2020) 36
FIGURE 7 EUROPEAN INJECTABLE DRUG DELIVERY MARKET, BY DEVICES (2015-2020): SELF-INJECTION DEVICES TO WITNESS HIGHEST GROWTH RATE 37
FIGURE 8 HOSPITALS/CLINICS FORM THE LARGEST END-USER SEGMENT IN 2014 38
FIGURE 9 EUROPEAN INJECTABLE DRUG DELIVERY MARKET, BY THERAPEUTIC APPLICATION (2015-2020): HORMONAL DISORDERS SEGMENT DOMINATES MARKET 39
FIGURE 10 EUROPEAN INJECTABLE DRUG DELIVERY FORMULATIONS MARKET TO GROW AT THE HIGHEST CAGR FROM 2015 TO 2020 40
FIGURE 11 THE CURATIVE CARE SEGMENT TO WITNESS THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD 41
FIGURE 12 HOME CARE SETTINGS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE IN 2015 42
FIGURE 13 HORMONAL DISORDERS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET IN 2015 43
FIGURE 14 INJECTABLE DRUG DELIVERY MARKET SEGMENTATION, BY TYPE 46
FIGURE 15 INJECTABLE DRUG DELIVERY MARKET SEGMENTATION, BY THERAPEUTIC APPLICATION 46
FIGURE 16 INJECTABLE DRUG DELIVERY MARKET SEGMENTATION, BY USAGE PATTERN 47
FIGURE 17 INJECTABLE DRUG DELIVERY MARKET SEGMENTATION, BY MODE OF ADMINISTRATION 47
FIGURE 18 INJECTABLE DRUG DELIVERY MARKET SEGMENTATION, BY END USER 47
FIGURE 19 INJECTABLE DRUG DELIVERY MARKET SEGMENTATION, BY REGION 48
FIGURE 20 RISING PREVALENCE OF CHRONIC DISEASES POPULATION WILL DRIVE THE MARKET GROWTH 49
FIGURE 21 EUROPE: INJECTABLE DRUG DELIVERY MARKET, BY THERAPEUTIC APPLICATION, 2013 - 2020 ($MILLION) 139
FIGURE 22 THERAPEUTIC APPLICATIONS: GERMANY TO SHOW HIGHEST GROWTH 140
FIGURE 23 EUROPEAN INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN: CURATIVE CARE TO HOLD LARGEST SHARE 162
FIGURE 24 EUROPE: INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION: SKIN SEGMENT TO SHOW HIGHEST GROWTH 167
FIGURE 25 EUROPE: INJECTABLE DRUG DELIVERY MARKET, BY END USER 173
FIGURE 26 EUROPE: EUROPEAN INJECTABLE DRUG DELIVERY MARKET, BY END USER: HOSPITALS/CLINICS TO HOLD LARGEST SHARE 173
FIGURE 27 EUROPE: FORMULATIONS MARKET SNAPSHOT 180
FIGURE 28 ROE: SELF-INJECTION DEVICES MARKET SNAPSHOT 201
FIGURE 29 KEY PLAYERS ADOPTED ORGANIC GROWTH STRATEGIES BETWEEN 2012 and 2015 206
FIGURE 30 GLOBAL INJECTABLE DRUG DELIVERY MARKET SHARE, BY KEY PLAYER (2014) 207
FIGURE 31 MARKET EVOLUTION FRAMEWORK: PARTNERSHIPS, AGREEMENTS AND COLLABORATIONS, and EXPANSIONS ARE FUELING MARKET GROWTH ,2014 and2015 208
FIGURE 32 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY LEADING PLAYERS FOLLOWED, 2013 209
FIGURE 33 PRODUCT BENCHMARKING FOR TOP 5 PLAYERS 214
FIGURE 34 BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT 215
FIGURE 35 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 218
FIGURE 36 GERRESHEIMER AG: COMPANY SNAPSHOT 221
FIGURE 37 PFIZER, INC.: COMPANY SNAPSHOT 223
FIGURE 38 SCHOTT AG: COMPANY SNAPSHOT 226
FIGURE 39 ALKERMES PLC: COMPANY SNAPSHOT 228
FIGURE 40 ELI LILLY AND COMPANY: COMPANY SNAPSHOT 230
FIGURE 41 SANDOZ: COMPANY SNAPSHOT 232
FIGURE 42 TERUMO CORPORATION: COMPANY SNAPSHOT 235
FIGURE 43 TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT 237

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
North American Drug Delivery Technologies Market by Route of Administration, Pulmonary, Injectable, Ocular, Nasal, Topical, Implantable), End User - Global Forecast to 2021

North American Drug Delivery Technologies Market by Route of Administration, Pulmonary, Injectable, Ocular, Nasal, Topical, Implantable), End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The North American drug delivery technologies market is projected to reach USD 758.7 billion by 2021 from USD 520.0 billion in 2016, at a CAGR of 6.5% during the forecast period. Major factors contributing ...

Syringes Market by Usability & Disposable Syringes), Material, Type - Global Forecast to 2021

Syringes Market by Usability & Disposable Syringes), Material, Type - Global Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The syringes market is expected to reach USD 15.99 billion by 2021, at a CAGR of 8.7% from 2016 to 2021. The syringes market is primarily driven by the high prevalence of chronic diseases across the globe. ...

Injectable Drug Delivery Market Analysis, By Device Type, By Formulation, By Therapeutic Use, By End-user Application, By Region And Segment Forecasts From 2013 to 2024

Injectable Drug Delivery Market Analysis, By Device Type, By Formulation, By Therapeutic Use, By End-user Application, By Region And Segment Forecasts From 2013 to 2024

  • $ 4950
  • Industry report
  • August 2016
  • by Grand View Research

The global injectable drug delivery market is expected to reach USD 931.1 billion by 2024, according to a new report by Grand View Research, Inc. The increase in number of chronic diseases like diabetes ...

Drug Injection Devices To 2024

August 2016 $ 3850

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.